Progress on Regulating Immune Barrier of Atopic Dermatitis by Jianpi Yangxue Qufeng Decoction

Yang YANG; Xue-song YANG; Jian-zhou YE; Hong-ying LI; Si-xuan CHEN

doi:10.12259/j.issn.2095-610X.S20210220

Volume 42 Issue 2

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2021 > 42(2): 140-146

Yang YANG, Xue-song YANG, Jian-zhou YE, Hong-ying LI, Si-xuan CHEN. Progress on Regulating Immune Barrier of Atopic Dermatitis by Jianpi Yangxue Qufeng Decoction[J]. Journal of Kunming Medical University, 2021, 42(2): 140-146. doi: 10.12259/j.issn.2095-610X.S20210220

Citation:

Yang YANG, Xue-song YANG, Jian-zhou YE, Hong-ying LI, Si-xuan CHEN. Progress on Regulating Immune Barrier of Atopic Dermatitis by Jianpi Yangxue Qufeng Decoction[J]. Journal of Kunming Medical University, 2021, 42(2): 140-146. doi: 10.12259/j.issn.2095-610X.S20210220

Citation:

PDF( 670 KB)

Progress on Regulating Immune Barrier of Atopic Dermatitis by Jianpi Yangxue Qufeng Decoction

doi: 10.12259/j.issn.2095-610X.S20210220

Dept. of Dermatology，The 1st Affiliated Hospital of Yunnan University of Traditional Chinese Medicine，Kunming Yunnan 650021，China

Received Date: 2020-11-13
Publish Date: 2021-02-25

Abstract

Abstract

Atopic dermatitis（AD）also known as atopic eczema, Besnier prurigo diathesique or hereditary allergic eczema, is a skin disease characterized by eczema-like skin lesions, severe itching and obvious "atopy" in oneself or his family. In recent years, the theory of AD pathogenesis tends to be abnormal in immune barrier function. At present, it has been found that the method of Jianpi Yangxue Qufeng Decoction has definite curative effect in treating AD with Xuexu Fengzao type, which can effectively control skin lesions, reduce recurrence rate and regulate the immune barrier function of AD. This article reviews the mechanism of regulating the immune barrier function of AD by the method of Jianpi Yangxue Qufeng Decoction.
- Atopic dermatitis,
- Jianpi yangxue qufeng decoction,
- Immune barrier function

FullText(HTML)

References(45)

References

[1]	Gandhi N A,Pirozzi G,Graham N M H. Commonality of the IL-4/IL-13 pathway in atopic diseases[J]. Expert Review of Clinical Immunology,2017,13(5):425-437. doi: 10.1080/1744666X.2017.1298443
[2]	王丽芬,叶建州,杨雪松. 健脾养血祛风汤治疗血虚风燥型特应性皮炎患者临床疗效及对患者皮肤屏障功能的影响[J]. 中国实验方剂学杂志,2018,24(13):178-182.
[3]	朱慧婷,尚宝令,李伯华,等. 健脾润肤汤对特应性皮炎脾虚证患者细胞因子的影响[J]. 西部中医药,2018,31(9):1-4. doi: 10.3969/j.issn.1004-6852.2018.09.001
[4]	Novak N,Koch S,Allam J P,et al. Dendritic cells:Bridging innate and adaptive immunity in atopic dermatitis[J]. J Allergy Clin Immunol,2010,125(1):50-59. doi: 10.1016/j.jaci.2009.11.019
[5]	Hvid M,Vestergaard C,Kemp K,et al. IL-25 in atopic dermatitis:a possible link between inflammation and skin barrier dysfunction[J]. Invest Dermatol,2011,131(1):150-157. doi: 10.1038/jid.2010.277
[6]	杨雪松,叶建州,罗光云,等. 健脾养血祛风方对树突状细胞 TLRs/MyD88/NF-kB 信号通路的干预机制[J]. 昆明医科大学学报,2019,40(11):13-20. doi: 10.3969/j.issn.1003-4706.2019.11.003
[7]	Sun,Lixiang,Wenjie Liu,Ling-juan Zhang. The role of toll-like receptors in skin host defense,psoriasis,and atopic dermatitis[J]. Journal of Immunology,2019,14(2019):1824624.
[8]	Yu Y,Lin D,Cai X,et al. Enhancement of chemokine mRNA expression by toll-like receptor 2 stimulation in human peripheral blood mononuclear cells of patients with atopic dermatitis[J]. BioMed Research International,2020,19:1497175.
[9]	白书仙,卫静,贺琪,等. 健脾养血汤对特异性皮炎小鼠模型中Toll样受体的表达影响及意义[J]. 江西中医药大学学报,2020,32(1):90-92.
[10]	Antiga E,Volpi W,Torchia D,et al. Effects of tacrolimus ointment on Toll-like receptors in atopic dermatitis[J]. Clinical and Experimental Dermatology,2011,36(3):235-241. doi: 10.1111/j.1365-2230.2010.03948.x
[11]	Nakamura N,Tamagawa-Mineoka R,Ueta M,et al. Stratum corneum toll-like receptor 3 expressions correlate with the severity of atopic dermatitis lesions[J]. Journal of Dermatological Science,2019,94(3):354-357. doi: 10.1016/j.jdermsci.2019.05.005
[12]	Liu Y J. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation[J]. J Allergy Clin Immunol,2007,120(2):238-244. doi: 10.1016/j.jaci.2007.06.004
[13]	Zimmermann M,Koreck A,Meyer N,et al. THF-like weak inducer of apoptosis(TWEAK)and TNF-α cooperate in the induction of keratinocyte apoptosis[J]. J Allergy Clin Immunol,2011,127(1):200-210. doi: 10.1016/j.jaci.2010.11.005
[14]	孙晓冬,游洋,刘岩,等. 当归饮子治疗特应性皮炎的疗效分析及对患者免疫功能调节作用研究[J]. 长春中医药大学学报,2018,36(6):1153-1156.
[15]	郑永平,陈高飞,张玲,等. 补脾祛风方对脾虚型特应性皮炎患者血清总免疫球蛋白、嗜酸性粒细胞的影响[J]. 国际中医中药杂志,2012,34(5):407-408. doi: 10.3760/cma.j.issn.1673-4246.2012.05.007
[16]	苏传丽,吴志洪. 红花逍遥片对血虚风燥型特应性皮炎患者免疫因子影响的研究[J]. 实用中西医结合临床,2015,15(10):10-13.
[17]	Sonkoly E,Janson P,Majuri M L,et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4[J]. J Allergy Clin Immunol,2010,126(3):581-589. e20.
[18]	Ma L,Xue H B,Wang F,et al. MicroRNA-155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17(Th17)cells[J]. Clin Exp Immunol,2015,181(1):142-149. doi: 10.1111/cei.12624
[19]	吴志洪,苏传丽,钟江,等. 不同证型特应性皮炎患者皮损microRNAs表达谱的研究[J]. 南京中医药大学学报,2017,33(1):14-18.
[20]	Paller A S,Kong H H,Seed P,et al. The microbiome in patients with atopic dermatitis[J]. J Allergy Clin Immunol,2019,143(1):26-35. doi: 10.1016/j.jaci.2018.11.015
[21]	Yockey L J,Demehri S,Turkoz M,et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation[J]. Invest Dermatol,2013,133(12):2714-2721. doi: 10.1038/jid.2013.228
[22]	Bjerkan L,Schreurs O,Engen S A,et al. The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide[J]. Mucosal Immunol,2015,8(1):49-56. doi: 10.1038/mi.2014.41
[23]	Kim H S,Yun J W,Shin T H,et al. Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-beta1 alleviate atopic dermatitis by reducing mast cell degranulation[J]. Stem Cells,2015,33(4):1254-1266. doi: 10.1002/stem.1913
[24]	Park H, Lee S, Yu Y, et al. TGF-β secreted by human umbilical cord blood-derived mesenchymal stem cells ameliorates atopic dermatitis by inhibiting secretion of TNF-α and IgE[J]. Stem Cells, 2020, 11. doi: 10.1002/stem.3183. Epub ahead of print. PMID: 32277785.
[25]	Yoshihara Y,Ishiuji Y,Yoshizaki A,et al. IL-10-Producing regulatory B cells are decreased in patients with atopic dermatitis[J]. J Invest Dermatol,2019,139(2):475-478. doi: 10.1016/j.jid.2018.08.016
[26]	Saulep-Easton D. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLLB cells[J]. Leukemia,2015,30(1):163-172.
[27]	Jee H M,Kim K W,Hong J Y,et al. Increased serum B cell-activating factor Level in children with atopic dermatitis[J]. Clin Exp Dermatol,2010,35(6):593-598.
[28]	Hayashi M,Yanaba K,Umezawa Y,et al. IL-10-producing regulatory B cells are decreased in patients with psoriasis[J]. J Dermatol Sci,2016,81(2):93-100. doi: 10.1016/j.jdermsci.2015.11.003
[29]	Gu Y,Li K,Sun J,et al. Characterization of CD19⁺CD24^hiCD38^hiB cells in chinese adult patients with atopic dermatitis[J]. European Academy of Dermatology and Venereology,2020,34(12):2863-2870. doi: 10.1111/jdv.16399
[30]	Silverberg J I. Atopic dermatitis treatment:Current state of the art and emerging therapies[J]. Allergy Asthma Proc,2017,38(4):243-249. doi: 10.2500/aap.2017.38.4054
[31]	Simpson E L, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis [ J]. N Engl J Med, 2016, 375（24）: 2335-2348.
[32]	Shah N,Alhusayen R,Walsh S,et al. Methotrexate in the treatment of moderate to severe atopic dermatitis:A retrospective study[J]. J Cutan Med Surg,2018,22(5):484-487. doi: 10.1177/1203475418781336
[33]	Udkoff J,Waldman A,Ahluwalia J,et al. Current and emerging topical therapies for atopic dermatitis[J]. Clin Dermatol,2017,35(4):375-382. doi: 10.1016/j.clindermatol.2017.03.010
[34]	秦万章. 血燥证理论在皮肤科中的应用[J]. 中国中西医结合皮肤性病学杂志,2014,13(1):1-6.
[35]	黄业坚,刘俊峰,陈达灿,等. 陈达灿教授治疗特应性皮炎经验浅谈[J]. 中国中西医结合皮肤性病学杂志,2010,9(3):165-166.
[36]	张斌,熊述清,杜泽敏,等. 国医大师禤国维治疗特应性皮炎临床经验探析[J]. 江苏中医药杂志,2019,51(2):17-20.
[37]	姚守恩,周渐云. 许铣治疗异位性皮炎经验[J]. 实用中医药杂志,2006,22(2):116. doi: 10.3969/j.issn.1004-2814.2006.02.056
[38]	郭静,肖敏,彭丽,等. 艾儒棣从脾胃论治小儿特应性皮炎经验[J]. 中华中医药杂志,2017,32(8):3534-3536.
[39]	李晨帅. 任勤教授辨治儿童特应性皮炎临床经验[J]. 中医儿科杂志,2019,15(4):21-23.
[40]	何丹,林青,王妍. 特应性皮炎的中医辨证及用药规律[J]. 云南中医学院学报,2009,32(4):66-67. doi: 10.3969/j.issn.1000-2723.2009.04.023
[41]	叶建州,杨雪松,李钦. 健脾养血祛风法对小鼠皮肤屏障功能影响的实验研究[J]. 云南中医中药杂志,2012,33(12):58-60. doi: 10.3969/j.issn.1007-2349.2012.12.034
[42]	杨雪松,叶建州,李钦. 健脾养血祛风法治疗特应性皮炎临床疗效及对皮肤屏障功能的影响[J]. 云南中医中药杂志,2009,32(3):5-7,12.
[43]	王丽芬,杨雪松,叶建州. 健脾养血祛风汤治疗血虚风燥型特应性皮炎的疗效及对患者血清LTB4、LTC4水平的影响[J]. 时珍国医国药,2018,29(3):641-643.
[44]	彭勇,李斌,王英杰,等. 健脾祛风方治疗脾虚型特应性皮炎临床疗效评价[J]. 中医药导报,2013,19(5):11-13. doi: 10.3969/j.issn.1672-951X.2013.05.005
[45]	陈保疆. 养血健脾润肤法治疗特应性皮炎临床疗效观察及对患者血清白细胞介素18的影响[J]. 中国中西医结合皮肤性病学杂志,2014,13(5):283-285. doi: 10.3969/j.issn.1672-0709.2014.05.004

Relative Articles(20)

Relative Articles

[1]	Xinbang WANG, An HU, Xipeng ZHAO, Yan WANG, Wei DING, Lipeng CAO, Yu GU, Ke XU, Yunfeng ZHANG. Effect of Ommaya Capsule on Cerebral Hemorrhage Complicated with Acute Hydrocephalus and its Effect on Blood-brain Barrier Function. Journal of Kunming Medical University, 2024, 45(10): 96-104. doi: 10.12259/j.issn.2095-610X.S20241015
[2]	Xinrui WAN, Xiaoyan WANG, Lin WANG, Zhiqiang MA, Caixin LI, Shitao XU, Xingrui TANG, Hongyan Mao. Liver，Kidney and Immunologic Function and Drug Resistance in Patients with Nontuberculous Mycobacteria Infection. Journal of Kunming Medical University, 2023, 44(11): 113-119. doi: 10.12259/j.issn.2095-610X.S20231117
[3]	Chenglin YANG, Jie HU, Jing WANG, Minhua WANG, Ling HUANG. Clinical Correletions between Helper T Cells 17，Regulatory T Cells and Chronic Actinic Dermatitis. Journal of Kunming Medical University, 2023, 44(5): 95-101. doi: 10.12259/j.issn.2095-610X.S20230511
[4]	Tongxin YANG, Guang WANG, Rui XU, Siwei SU, Kewei FANG, Jianhe LIU, Jiongming LI. Effect of Cathelicidin LL-37 on Transmembrane Barrier Function of Urothelial Cells. Journal of Kunming Medical University, 2022, 43(8): 34-40. doi: 10.12259/j.issn.2095-610X.S20220806
[5]	Zhao Shu Bo , Li Ai Lin , Liang Wu , Ning Jin Mei . . Journal of Kunming Medical University, 2020, 41(08): 105-110.
[6]	Xin-yue CHEN, Zong-han CHEN, Wei-jia ZHAO. Efficacy of Deside Cream Combined with Compound Polymyxin B Ointment in the Treatment of Moderate-severe Atopic Dermatitis in Children. Journal of Kunming Medical University, 2020, 41(12): 104-107. doi: 10.12259/j.issn.2095-610X.S20201228
[7]	Yu Xiao Dong , Long Jiang . . Journal of Kunming Medical University, 2019, 40(09): 68-71.
[8]	Yang Xue Song , Ye Jian Zhou , Luo Guang Yun , Li Bai Cheng , Gan Ning . . Journal of Kunming Medical University, 2019, 40(11): 13-20.
[9]	Wang Sheng Hu . Comparison of the Test Results between Automatic Enzyme-linked Immunity Analyzer and Manual Enzyme-linked Immunoassay. Journal of Kunming Medical University,
[10]	Lei Dong Yun . Clinical Retrospective Dermatology Study on 169 Cases of Chronic Actinic Dermatitis. Journal of Kunming Medical University,
[11]	Chen Zong 劼. . Journal of Kunming Medical University,
[12]	Liu Yan Nan . . Journal of Kunming Medical University,
[13]	Chen Juan . . Journal of Kunming Medical University,
[14]	Liang Zheng Ju . . Journal of Kunming Medical University,
[15]	Hu Xiao . . Journal of Kunming Medical University,
[16]	Guo Feng . . Journal of Kunming Medical University,
[17]	Ge Yu Ming . . Journal of Kunming Medical University,
[18]	Deng Dan Qi . . Journal of Kunming Medical University,
[19]	Zhu Xing Bao . . Journal of Kunming Medical University,
[20]	Zhang Yan Li . . Journal of Kunming Medical University,